APA (7th ed.) Citation

Sun, Y., Ren, S., Wen, W., Jing, J., Luo, X., Shao, S., . . . Guo, J. (2025). Targeting CXCR2 in prostate cancer cells can block CD47-SIRPα interaction and reverse M2 macrophage polarization in the TME. Molecular Cancer, 24(1), 1. https://doi.org/10.1186/s12943-025-02436-1

Chicago Style (17th ed.) Citation

Sun, Yi, Shangqing Ren, Wei Wen, Jun Jing, Xu Luo, Shuai Shao, Ruiqi Duan, Guohua Zeng, and Ju Guo. "Targeting CXCR2 in Prostate Cancer Cells Can Block CD47-SIRPα Interaction and Reverse M2 Macrophage Polarization in the TME." Molecular Cancer 24, no. 1 (2025): 1. https://doi.org/10.1186/s12943-025-02436-1.

MLA (9th ed.) Citation

Sun, Yi, et al. "Targeting CXCR2 in Prostate Cancer Cells Can Block CD47-SIRPα Interaction and Reverse M2 Macrophage Polarization in the TME." Molecular Cancer, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12943-025-02436-1.